Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CoreBone
Tel Aviv, Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
CoreBone has CE-marked bioactive coral-based bone grafts commercially distributed for dental and selected orthopedic indications in Europe and Israel, with thousands of successful dental graft procedures reported and ongoing clinical work in orthopedic-oncology; it is also developing a platform for articular cartilage regeneration.[3][4][5][6]
- Therapeutic areas
- OncologyRheumatologyOther
- Modalities
- DeviceBiologicBiomaterial
- Industry
- Implantable Medical Devices
02
Partnerships
Trendlines (medical incubator/support partner)[3][4]Multiple regional distributors in Europe and Asia (including Taiwan registration and planned distribution in Spain, Italy, Australia, India, Argentina, Chile, China, Japan)[4]
Beyond the preview
Go deeper on CoreBone.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CoreBone.